• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Arvinas

parachutes sky italy sun blue
Biotech

Pfizer’s reputation wrangler plans departure—Chutes & Ladders

Pfizer’s longtime reputation wrangler plans departure. AI unicorn lassos new president. Jazz switches tempo with female CEO.
Darren Incorvaia , Zoey Becker Jul 11, 2025 8:30am
layoffs

Arvinas lays off 33% of staff, axes Pfizer-partnered trials

May 1, 2025 8:50am
positive negative up down good bad mixed

Pfizer, Arvinas' PROTAC posts mixed results in first ph. 3 test

Mar 11, 2025 10:06am
parachute south africa cape town

Marea, Ashibio, Arvinas & more—Chutes & Ladders

Jun 21, 2024 8:30am
parachute mountains sunset clouds

Xaira, Anthos, CureVac & more—Chutes & Ladders

Apr 26, 2024 8:30am
Three blocks displaying from left to right a person a handshake and another person

Novartis pays $150M for Arvinas' prostate tumor protein degrader

Apr 11, 2024 8:04am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings